27715026|t|Therapeutic Delivery of H2S via COS: Small Molecule and Polymeric Donors with Benign Byproducts
27715026|a|Carbonyl sulfide (COS) is a gas that may play important roles in mammalian and bacterial biology, but its study is limited by a lack of suitable donor molecules. We report here the use of N-thiocarboxyanhydrides (NTAs) as COS donors that release the gas in a sustained manner under biologically relevant conditions with innocuous peptide byproducts. Carbonic anhydrase converts COS into H2S, allowing NTAs to serve as either COS or H2S donors, depending on the availability of the enzyme. Analysis of the pseudo-first-order H2S release rate under biologically relevant conditions revealed a release half-life of 75 min for the small molecule NTA under investigation. A polynorbornene bearing pendant NTAs made by ring-opening metathesis polymerization was also synthesized to generate a polymeric COS / H2S donor. A half-life of 280 min was measured for the polymeric donor. Endothelial cell proliferation studies revealed an enhanced rate of proliferation for cells treated with the NTA over untreated controls.
27715026	0	11	Therapeutic	T061	C0087111
27715026	12	20	Delivery	T169	C1705822
27715026	24	27	H2S	T130,T131,T197	C0020282
27715026	32	35	COS	T197	C0054714
27715026	37	51	Small Molecule	T109	C1328819
27715026	56	65	Polymeric	T104,T122	C0032521
27715026	66	72	Donors	T167	C0567416
27715026	78	84	Benign	T080	C0205183
27715026	85	95	Byproducts	T071	C1514468
27715026	96	112	Carbonyl sulfide	T197	C0054714
27715026	114	117	COS	T197	C0054714
27715026	124	127	gas	T104	C0017110
27715026	161	170	mammalian	T015	C0024660
27715026	175	184	bacterial	T007	C0004611
27715026	185	192	biology	T091	C0005532
27715026	202	207	study	T062	C2603343
27715026	241	256	donor molecules	T167	C0567416
27715026	261	267	report	T170	C0684224
27715026	284	307	N-thiocarboxyanhydrides	T109	C0003030
27715026	309	313	NTAs	T109	C0003030
27715026	318	321	COS	T197	C0054714
27715026	322	328	donors	T167	C0567416
27715026	346	349	gas	T104	C0017110
27715026	378	390	biologically	T080	C0205460
27715026	400	410	conditions	T080	C0348080
27715026	426	433	peptide	T116	C0030956
27715026	434	444	byproducts	T071	C1514468
27715026	446	464	Carbonic anhydrase	T116,T126	C0007028
27715026	474	477	COS	T197	C0054714
27715026	483	486	H2S	T130,T131,T197	C0020282
27715026	497	501	NTAs	T109	C0003030
27715026	521	524	COS	T197	C0054714
27715026	528	531	H2S	T130,T131,T197	C0020282
27715026	532	538	donors	T167	C0567416
27715026	577	583	enzyme	T116,T126	C0014442
27715026	585	593	Analysis	T062	C0936012
27715026	601	619	pseudo-first-order	T169	C0443286
27715026	620	623	H2S	T130,T131,T197	C0020282
27715026	624	636	release rate	T081	C1521828
27715026	643	655	biologically	T080	C0205460
27715026	665	675	conditions	T080	C0348080
27715026	695	704	half-life	T079	C0018517
27715026	711	714	min	T079	C0439232
27715026	723	737	small molecule	T109	C1328819
27715026	738	741	NTA	T109	C0003030
27715026	765	779	polynorbornene	T109	C2606633
27715026	796	800	NTAs	T109	C0003030
27715026	809	847	ring-opening metathesis polymerization	T067	C0314672
27715026	857	868	synthesized	T052	C1883254
27715026	872	880	generate	T052	C3146294
27715026	883	892	polymeric	T104,T122	C0032521
27715026	893	896	COS	T197	C0054714
27715026	899	902	H2S	T130,T131,T197	C0020282
27715026	903	908	donor	T167	C0567416
27715026	912	921	half-life	T079	C0018517
27715026	929	932	min	T079	C0439232
27715026	954	963	polymeric	T104,T122	C0032521
27715026	964	969	donor	T167	C0567416
27715026	971	1001	Endothelial cell proliferation	T043	C1655807
27715026	1002	1009	studies	T062	C2603343
27715026	1039	1062	proliferation for cells	T043	C0596290
27715026	1063	1070	treated	T169	C1522326
27715026	1080	1083	NTA	T109	C0003030
27715026	1089	1098	untreated	T033	C0332155
27715026	1099	1107	controls	T096	C0009932